• Home
  • Daily
  • Free Services
    • Reports
    • Webinars
    • Videos
    • Daily
  • Premium Services
    • Prime Pro Membership
    • Prime Membership
    • Cabot Retirement Club
    • Advisories
      • Cabot Dividend Investor
      • Cabot Early Opportunities
      • Cabot Global Stocks Explorer
      • Cabot Growth Investor
      • Cabot Income Advisor
      • Cabot Marijuana Investor
      • Cabot Micro-Cap Insider
      • Cabot Options Trader
      • Cabot Options Trader Pro
      • Cabot Profit Booster
      • Cabot Small-Cap Confidential
      • Cabot Stock of the Week
      • Cabot Top Ten Trader
      • Cabot Turnaround Letter
      • Cabot Undervalued Stocks Advisor
      • View All
    • Summit
  • My Services
  • Daily Archive
  • Browse Topics
    • How To Invest
    • Value Investing
    • Growth Stocks
    • Stock Market
    • Dividend Stocks
    • Options Trading
    • Emerging Markets
    • Small-Cap Stocks
    • Income Investing
    • ETFs
    • View All Topics
  • Stock Picks
  • Keyword Index
  • Analyst Index
  • Manage Account
  • About
    • About Us
    • Learn
      • Glossary
      • Chart School
      • Stock Market Timing Indicators
      • Manage Your Own Money
    • Webinars
    • Buttons
  • Contact Us
  • Privacy Policy, Terms of Use & Premium Service Terms & Conditions
  • RSS Feed
  • All Investing Lessons
  • Start Investing
  • Investing FAQs

Cabot Wealth Network Logo

  • Home
  • Daily
  • Free Services
    • Reports
    • Webinars
    • Videos
    • Daily
  • Premium Services
    • Prime Pro Membership
    • Prime Membership
    • Cabot Retirement Club
    • Advisories
      • Cabot Dividend Investor
      • Cabot Early Opportunities
      • Cabot Global Stocks Explorer
      • Cabot Growth Investor
      • Cabot Income Advisor
      • Cabot Marijuana Investor
      • Cabot Micro-Cap Insider
      • Cabot Options Trader
      • Cabot Options Trader Pro
      • Cabot Profit Booster
      • Cabot Small-Cap Confidential
      • Cabot Stock of the Week
      • Cabot Top Ten Trader
      • Cabot Turnaround Letter
      • Cabot Undervalued Stocks Advisor
      • View All
    • Summit
  • My Services
  • About
  • Sign In
  • Register
  • | Register
  • Sign In
  • Register
  • | Register

analyst upgrades Archives

Cabot Prime Pro Week Ending March 5, 2021

From the Cabot Prime Pro Week Ending March 5, 2021 issue of Cabot Prime Pro|by Cabot Wealth Network|Cabot Prime Pro

Stock Recommendation Tracker The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More

Cabot Small-Cap Confidential Special Bulletin

March 5, 2021|From Cabot Small-Cap Confidential|by Tyler Laundon|Small Cap Stocks

Suffice to say the last two weeks have been very tough. On the one hand, yes, of course some sort of correction or pullback has been expected given the huge progress the market – and growth stocks, small caps and IPOs in particular have...
Read More

Cabot Growth Investor Bi-weekly Update

March 4, 2021|From Cabot Growth Investor|by Mike Cintolo|Growth Stocks

The sellers ran wild today, with the Dow losing 346 points, the Nasdaq falling 274 points (2.1%) and the average growth stock we own or watch down nearly 5%. From late January through late February, we began to see a change in character, a..
Read More

Cabot Small-Cap Confidential Special Bulletin

March 3, 2021|From Cabot Small-Cap Confidential|by Tyler Laundon|Small Cap Stocks

Arena Pharmaceuticals (ARNA) yesterday announced that olorinab failed to meet the primary endpoint in the Phase 2 CAPTIVATE study in IBS abdominal pain. This is disappointing but not remotely the reason to own (or sell) the stock. IBS is a difficult to treat condition when...
Read More

Cabot Undervalued Stocks Advisor 321

From the Cabot Undervalued Stocks Advisor 321 issue of Cabot Undervalued Stocks Advisor|by Bruce Kaser|Value Investing

We’re watching market sentiment gyrate sharply between “the economic reopening will boost earnings” and “the economic reopening will boost inflation”. Both outcomes are likely.
Read More

Cabot Small-Cap Confidential Special Bulletin

March 1, 2021|From Cabot Small-Cap Confidential|by Tyler Laundon|Small Cap Stocks

Cardlytics (CDLX) reported Q4 2020 numbers this morning that surpassed revenue expectations by roughly 10% and missed modestly on earnings. Revenue was down 3.2% to $67.1 million (beating by $6.2 million) while adjusted EPS of -$0.05 missed by $0.02. Management gave 2021 guidance that for...
Read More

Cabot Small-Cap Confidential Special Bulletin

February 26, 2021|From Cabot Small-Cap Confidential|by Tyler Laundon|Small Cap Stocks

Personalis (PSNL) released preliminary Q4 results on January 11 and the official release after the close yesterday offered no surprises. Personalis (PSNL) Moves To SELL
Read More

Cabot Prime Pro Week Ending February 26, 2021

From the Cabot Prime Pro Week Ending February 26, 2021 issue of Cabot Prime Pro|by Cabot Wealth Network|Cabot Prime Pro

Stock Recommendation Tracker The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More

Cabot Growth Investor 1466

From the Cabot Growth Investor 1466 issue of Cabot Growth Investor|by Mike Cintolo|Growth Stocks

More Cracks Appear At the start of November we saw a couple of blastoff-type indicators flash green (like the Three Day Thrust rule), and that turned out to be the start of a powerful intermediate-term advance. During the next two-plus months, progress was relative there...
Read More

Cabot Small-Cap Confidential Special Bulletin

February 24, 2021|From Cabot Small-Cap Confidential|by Tyler Laundon|Small Cap Stocks

Sprout Social (SPT) reported Q4 results yesterday that surpassed expectations. Revenue was up 32.6% to $37.3 million (beating by $1.4 million) while adjusted EPS of -$0.06 beat by $0.05. Guidance for 2021 looks solid with management calling for 2021 revenue of $172.5 million (up modestly...
Read More

Cabot Prime Pro Week Ending February 19, 2021

From the Cabot Prime Pro Week Ending February 19, 2021 issue of Cabot Prime Pro|by Cabot Wealth Network|Cabot Prime Pro

Stock Recommendation Tracker The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More

Cabot Small-Cap Confidential Special Bulletin

February 19, 2021|From Cabot Small-Cap Confidential|by Tyler Laundon|Small Cap Stocks

Everbridge (EVBG) reported Q4 results yesterday that exceeded expectations on both the top and bottom lines and have sent shares soaring over 20% to a new all-time high this morning. Part of the reason is that the stock has been consolidating forever and is of...
Read More

Cabot Growth Investor Bi-weekly Update

February 18, 2021|From Cabot Growth Investor|by Mike Cintolo|Growth Stocks

The market took another hit this morning, but like yesterday, the major indexes have found support as the day has progressed—just after 3 pm EST, the Dow was down 70 points while the Nasdaq was off 66 points. Part of the reason for recent...
Read More

Cabot Prime Pro Week Ending February 12, 2021

From the Cabot Prime Pro Week Ending February 12, 2021 issue of Cabot Prime Pro|by Cabot Wealth Network|Cabot Prime Pro

Stock Recommendation Tracker The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More

Cabot Small-Cap Confidential Special Bulletin

February 12, 2021|From Cabot Small-Cap Confidential|by Tyler Laundon|Small Cap Stocks

Since reporting earnings earlier this week shares of Avalara (AVLR) have retreated modestly, despite a solid quarter. As I’ve flipped through dozens of charts over the last two days I’ve been struck by the diverging performance of earnings winners.
Read More

Cabot Growth Investor 1465

From the Cabot Growth Investor 1465 issue of Cabot Growth Investor|by Mike Cintolo|Growth Stocks

Simply Put: Very Impressive Action Two weeks ago, the major indexes and some individual stocks began to flash abnormal action, a couple of key leaders were threatening to break down and some late-in-the-advance type of action (heavily shorted stocks going nuts) was occurring. Importantly, the...
Read More

Cabot Small-Cap Confidential Special Bulletin

February 11, 2021|From Cabot Small-Cap Confidential|by Tyler Laundon|Small Cap Stocks

Avalara (AVLR) reported results after the close yesterday that handily beat expectations on virtually all metrics. Q4 revenue was up 35% to $144.8 million (beating by $11.4 million) while adjusted EPS of $0.09 beat by $0.15. Billings of $167 million were up 38%. Adjusted margin...
Read More

Cabot Small-Cap Confidential Special Bulletin

February 8, 2021|From Cabot Small-Cap Confidential|by Tyler Laundon|Small Cap Stocks

Cerence (CRNC) reported this morning that Q1 revenue was up 22.6% to $95 million (beating by $7.1 million) while adjusted EPS of $0.59 was up 103% (beating by $0.08). There are a lot of initiatives at Cerence and management had a lot to say, I’ll...
Read More

Cabot Prime Pro Week Ending February 5, 2021

From the Cabot Prime Pro Week Ending February 5, 2021 issue of Cabot Prime Pro|by Cabot Wealth Network|Cabot Prime Pro

Stock Recommendation Tracker The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any to...
Read More

Cabot Growth Investor Bi-weekly Update

February 4, 2021|From Cabot Growth Investor|by Mike Cintolo|Growth Stocks

The quick rebound in the major indexes and many growth stocks this week has been very encouraging—it doesn’t completely clear the air from some of the abnormal action last week, but it’s definitely a plus. We remain mostly bullish, though we continue to entries...
Read More

View Topics

  • Dividend Stocks
  • Emerging Markets
  • ETFs
  • Growth Stocks
  • How To Invest
  • Income Investing
  • Options Trading
  • Small Cap Stocks
  • Stock Market
  • Value Investing

Subscribe To

  • Cabot Top Ten Trader
  • Cabot Stock of the Week
  • Cabot Global Stocks Explorer
  • Cabot Small-Cap Confidential
  • Cabot Dividend Investor
  • Cabot Options Trader
  • Cabot Options Trader Pro

Customer Service

  • Manage My Account
  • Subscription Questions
Enter Your Log In Credentials

  • Lost your password? Create New Password
  • No account? Sign up
  • Manage Account
  • Subscribe
  • About
  • Contact Us
  • Privacy Policy, Terms of Use & Premium Service Terms & Conditions
  • Analyst Index
  • Keyword Index
  • Daily Archive
  • RSS Feed

Copyright © 2021 Cabot Wealth Network
Cabot Heritage Corporation
176 North Street, Salem, MA 01970
Phone: (800) 326-8826
Fax: (978) 745-1283
Email: support@cabotwealth.com

Powered by Mequoda Systems

Subscribe to Our Newsletter

Discover the hottest stocks, investing tips and analysis from Cabot analysts in our free Cabot Wealth Daily newsletter delivered right to your inbox.

Cabot Wealth 50th anniversary